SCHEMBL4013558

SCHEMBL4013558

O=c1[nH]c(=O)n(-c2ccccc2)c2nc(-c3c[nH]nc3Cc3ccccc3)[nH]c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.42
ADORA2B P29275 2/20 0.42
KMT2A Q03164 4/20 0.40
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 3/20 0.40
HSD17B10 Q99714 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GLA P06280 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
TSHR P16473 2/20 0.39
GAA P10253 2/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
XBP1 P17861 1/20 0.39
MAPK1 P28482 1/20 0.39
ATM Q13315 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MEN1 O00255 2/20 0.36
USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4020309 0.83 ADORA2B (0.40) ADORA2AADORA2BKMT2AALDH1A1KDM4E
SCHEMBL4013805 0.82 ADORA2A (0.43) ADORA2AADORA2BKMT2AALDH1A1KDM4E
SCHEMBL4021124 0.79 AKT2 (0.38) ADORA2AADORA2BKMT2AALDH1A1KDM4E
SCHEMBL7604058 0.77 PNP (0.51) ADORA2AADORA2BKMT2ASMN1; SMN2TSHR
SCHEMBL4176128 0.73 ADORA2B (0.62) ADORA2AADORA2BKMT2AALDH1A1KDM4E
SCHEMBL1945095 0.72 ADORA2B (0.60) ADORA2AADORA2BADORA3
SCHEMBL7421517 0.70 PNP (0.46) KMT2AALDH1A1SMN1; SMN2TSHRGAA
SCHEMBL19211636 0.69 CSNK2A1 (0.42) ADORA2AADORA2BKMT2AALDH1A1KDM4E
SCHEMBL3554510 0.69 CSNK2A1 (0.43) ADORA2AADORA2BKMT2AALDH1A1KDM4E
SCHEMBL7421927 0.68 CCNE2 (0.46) KMT2AKDM4ESMN1; SMN2TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009088518-A1 A2B ADENOSINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CANCER CV THERAPEUTICS, INC. (US) 2009-07-16 WO disclosed